Fig. 5.
RFS (a) and OS (b) in patients with primary GIST treated with 1 versus 3 years of adjuvant imatinib in the SSGXVIII/AIO phase III trial13
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.